The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...
In less than 36 hours between the evening of Jan. 12 and the morning of Jan. 14, three local life science companies raised a ...
Seventeen health systems are investing in a genomic database that could significantly drive down clinical costs. Truveta, a Washington-based software company, unveiled the Truveta Genome Project on ...
Health data company Truveta said Monday it’s partnering with health systems and drugmakers to launch the Truveta Genome Project, a database of genetic data that is expected to accelerate ...
The Bellevue, Wash.-based company describes its new Truveta Genome Project as the “largest and most diverse database of genotypic and phenotypic information ever assembled” that is more than ...
Several large drugmakers will ask the Trump administration to pause Medicare drug-price negotiations, even as Biden-appointed officials prepare a new list of medicines that should be targeted, ...
Medical data analytics company Truveta has secured $320 million in ... which is supplying its cloud computing program Azure to support its genome project. The healthcare partners plan to ask ...
US health systems and Regeneron Genetics Center launch the Truveta Genome Project, a $320M initiative to sequence up to 10M ...
Regeneron collaborates with Truveta to expand a genomic database, investing $119.5 million to enhance genetics-based healthcare research. Regeneron's $119.5 million investment in Truveta's Series ...
“Just like volunteering to be an organ donor on your driver’s license is a simple act of service with a profound impact, the Truveta Genome Project enables each of us to anonymously contribute ...
GeekWire’s startup coverage documents the Pacific Northwest entrepreneurial scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and venture capital ...
If all goes as planned, Myerson says, the Truveta Genome Project will unlock insights into patient care and propel drug discovery. “The world needed this to exist,” Myerson says. The Regeneron ...